The ligand-binding domains of the thyroid hormone/retinoid receptor gene subfamily function in vivo to mediate heterodimerization, gene silencing, and transactivation

The ligand-binding domains (LBDs) of the thyroid/retinoid receptor gene subfamily contain a series of heptad motifs important for dimeric interactions. This subfamily includes thyroid hormone receptors (T3Rs), all-trans retinoic acid (RA) receptors (RARs), 9-cis RA receptors (RARs and retinoid X receptors [RXRs]), the 1,25-dihydroxyvitamin D3 receptor (VDR), and the receptors that modulate the peroxisomal beta-oxidation pathway (PPARs). These receptors bind to their DNA response elements in vitro as heterodimers with the RXRs. Unliganded receptors in vivo, in particular the T3Rs, can mediate gene silencing and ligand converts these receptors into a transcriptionally active form. The in vivo interactions of these receptors with RXR were studied by using a GAL4-RXR chimera containing the yeast GAL4 DNA-binding domain and the LBD of RXR beta. GAL4-RXR activates transcription from GAL4 response elements in the presence of 9-cis RA. Unliganded T3R, which does not bind or activate GAL4 elements, represses the activation of GAL4-RXR by 9-cis RA in HeLa cells. However, addition of T3 alone leads to transcriptional activation. These findings suggest that T3R can repress or activate transcription while tethered to the LBD of GAL4-RXR and that heterodimerization can occur in vivo without stabilization by hormone response elements. Similar ligand-dependent activation was observed in HeLa cells expressing RAR, VDR, or PPAR and in GH4C1 cells from endogenous receptors. Replacement of the last 17 amino acids of the LBD of RXRbeta with the 90-amino-acid transactivating domain of the herpes simplex virus VP16 protein leads to a GAL4 constitutive activator that is repressed by wild-type T3R but not by a ninth heptad mutant that does not form heterodimers. This finding suggests that the ninth heptad or T3R is important for gene silencing and that the LBD of RXR does not exhibit silencing activity. This conclusion was verified with GAL4-LBD chimeras and with wild-type receptors in assays using appropriate response elements. These studies indicate that the LBD has diverse functional roles in gene regulation.

[1]  B. Raaka,et al.  The conserved ninth C-terminal heptad in thyroid hormone and retinoic acid receptors mediates diverse responses by affecting heterodimer but not homodimer formation , 1993, Molecular and cellular biology.

[2]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[3]  J. Harney,et al.  Thyroid hormone aporeceptor represses T3-inducible promoters and blocks activity of the retinoic acid receptor. , 1989, The New biologist.

[4]  M. Lazar,et al.  Thyroid hormone receptors form distinct nuclear protein-dependent and independent complexes with a thyroid hormone response element. , 1990, Molecular endocrinology.

[5]  C. Glass,et al.  Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer , 1989, Cell.

[6]  M. Galligan,et al.  Retinoid X receptors stimulate and 9-cis retinoic acid inhibits 1,25-dihydroxyvitamin D3-activated expression of the rat osteocalcin gene , 1993, Molecular and cellular biology.

[7]  B. O’Malley,et al.  Point mutations in the human vitamin D receptor gene associated with hypocalcemic rickets. , 1988, Science.

[8]  M. Rosenfeld,et al.  Regulation of pituitary function and prolactin production in the GH4 cell line by vitamin D. , 1981, The Journal of biological chemistry.

[9]  J. Shine,et al.  1,25-dihydroxyvitamin D-responsive element and glucocorticoid repression in the osteocalcin gene. , 1989, Science.

[10]  H. Samuels,et al.  The NF-kappa B and Sp1 motifs of the human immunodeficiency virus type 1 long terminal repeat function as novel thyroid hormone response elements , 1993, Molecular and cellular biology.

[11]  J. Bonventre,et al.  Kid-1, a putative renal transcription factor: regulation during ontogeny and in response to ischemia and toxic injury , 1993, Molecular and cellular biology.

[12]  J. Shine,et al.  Cloning and expression of full-length cDNA encoding human vitamin D receptor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[13]  H. Samuels,et al.  A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors. , 1989, Molecular endocrinology.

[14]  K. Umesono,et al.  Retinoic acid and thyroid hormone induce gene expression through a common responsive element , 1988, Nature.

[15]  J. Leatherwood,et al.  An amino-terminal fragment of GAL4 binds DNA as a dimer. , 1989, Journal of molecular biology.

[16]  D. Barettino,et al.  Characterization of the ligand‐dependent transactivation domain of thyroid hormone receptor. , 1994, The EMBO journal.

[17]  B. Vennström,et al.  Binding characteristics of the thyroid hormone receptor homo- and heterodimers to consensus AGGTCA repeat motifs. , 1992, Molecular endocrinology.

[18]  H. Samuels,et al.  Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation. , 1991, The Journal of biological chemistry.

[19]  B. Raaka,et al.  Half-site spacing and orientation determines whether thyroid hormone and retinoic acid receptors and related factors bind to DNA response elements as monomers, homodimers, or heterodimers. , 1992, Molecular endocrinology.

[20]  J. Y. Chen,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. , 1992, Cell.

[21]  B. O’Malley,et al.  COUP transcription factor is a member of the steroid receptor superfamily , 1989, Nature.

[22]  E. Appella,et al.  H‐2RIIBP (RXR beta) heterodimerization provides a mechanism for combinatorial diversity in the regulation of retinoic acid and thyroid hormone responsive genes. , 1992, The EMBO journal.

[23]  A. Mahfoudi,et al.  Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  K. Umesono,et al.  Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D3 signalling , 1992, Nature.

[25]  R. Evans,et al.  Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes , 1986, Nature.

[26]  K. Umesono,et al.  Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors , 1991, Cell.

[27]  I. Issemann,et al.  Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators , 1990, Nature.

[28]  P. Chambon,et al.  RARs and RXRs: evidence for two autonomous transactivation functions (AF‐1 and AF‐2) and heterodimerization in vivo. , 1993, The EMBO journal.

[29]  E. Appella,et al.  H-2RIIBP, a member of the nuclear hormone receptor superfamily that binds to both the regulatory element of major histocompatibility class I genes and the estrogen response element. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Philippe Kastner,et al.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently , 1992, Cell.

[31]  M. Karin,et al.  A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor) , 1993, Molecular and cellular biology.

[32]  M. Ptashne,et al.  A vector for expressing GAL4(1-147) fusions in mammalian cells. , 1989, Nucleic acids research.

[33]  Klaus Damm,et al.  Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist , 1989, Nature.

[34]  H. Samuels,et al.  c-erbA protooncogenes mediate thyroid hormone-dependent and independent regulation of the rat growth hormone and prolactin genes. , 1988, Molecular endocrinology.

[35]  M. Pfahl,et al.  Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors , 1992, Nature.

[36]  A. Cooney,et al.  Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone, and retinoic acid receptors , 1992, Molecular and cellular biology.

[37]  C. Glass,et al.  RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements , 1991, Cell.

[38]  D. Reinberg,et al.  Interaction of human thyroid hormone receptor beta with transcription factor TFIIB may mediate target gene derepression and activation by thyroid hormone. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[39]  J. Pike,et al.  Vitamin D receptor interaction with specific DNA. Association as a 1,25-dihydroxyvitamin D3-modulated heterodimer. , 1991, The Journal of biological chemistry.

[40]  H. Samuels,et al.  Characterization of the domain structure of chick c-erbA by deletion mutation: in vitro translation and cell transfection studies. , 1989, Molecular endocrinology.

[41]  R. Renkawitz,et al.  A transferable silencing domain is present in the thyroid hormone receptor, in the v‐erbA oncogene product and in the retinoic acid receptor. , 1992, The EMBO journal.

[42]  H. Samuels,et al.  pEXPRESS: a family of expression vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro. , 1991, Gene.

[43]  K. Dahlman-Wright,et al.  Protein-protein interactions facilitate DNA binding by the glucocorticoid receptor DNA-binding domain. , 1990, The Journal of biological chemistry.

[44]  B. Raaka,et al.  The herpes simplex virus thymidine kinase gene promoter contains a novel thyroid hormone response element. , 1993, Molecular endocrinology.

[45]  M. Lazar,et al.  Dominant negative activity of an endogenous thyroid hormone receptor variant (alpha 2) is due to competition for binding sites on target genes. , 1993, The Journal of biological chemistry.

[46]  M. Lazar,et al.  The unique C-termini of the thyroid hormone receptor variant, c-erbA alpha 2, and thyroid hormone receptor alpha 1 mediate different DNA-binding and heterodimerization properties. , 1992, Molecular endocrinology.

[47]  Jun Ma,et al.  GAL4-VP16 is an unusually potent transcriptional activator , 1988, Nature.

[48]  K. Umesono,et al.  Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors , 1992, Nature.

[49]  A. Aranda,et al.  Retinoic acid regulates growth hormone gene expression , 1989, Nature.

[50]  M. Galligan,et al.  Baculovirus-mediated expression of the human vitamin D receptor. Functional characterization, vitamin D response element interactions, and evidence for a receptor auxiliary factor. , 1991, The Journal of biological chemistry.

[51]  T. Nagaya,et al.  Thyroid hormone receptor dimerization is required for dominant negative inhibition by mutations that cause thyroid hormone resistance. , 1993, The Journal of biological chemistry.

[52]  K. Yamamoto,et al.  Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA , 2003, Nature.

[53]  S. McKnight,et al.  Functional dissection of VP16, the trans-activator of herpes simplex virus immediate early gene expression. , 1988, Genes & development.

[54]  H. Samuels,et al.  Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model. , 1990, Molecular endocrinology.

[55]  B. O’Malley,et al.  Kindred S thyroid hormone receptor is an active and constitutive silencer and a repressor for thyroid hormone and retinoic acid responses. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  M. Lazar,et al.  Identification of a rat c-erbA alpha-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone. , 1988, Molecular endocrinology.

[57]  T. Bugge,et al.  RXR alpha, a promiscuous partner of retinoic acid and thyroid hormone receptors. , 1992, The EMBO journal.

[58]  J. Lehmann,et al.  Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid , 1992, Nature.

[59]  H. Samuels,et al.  cis-acting elements of the rat growth hormone gene which mediate basal and regulated expression by thyroid hormone. , 1987, The Journal of biological chemistry.

[60]  H. Beug,et al.  v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA , 1990, Cell.

[61]  B. Raaka,et al.  Functional evidence for ligand-dependent dissociation of thyroid hormone and retinoic acid receptors from an inhibitory cellular factor , 1994, Molecular and cellular biology.

[62]  J. Harney,et al.  Mutations of the rat growth hormone promoter which increase and decrease response to thyroid hormone define a consensus thyroid hormone response element. , 1989, Molecular endocrinology.

[63]  Christine Dreyer,et al.  Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors , 1992, Cell.

[64]  B. O’Malley,et al.  Steroid receptor family: structure and functions. , 1990, Endocrine reviews.

[65]  L. Freedman,et al.  DNA sequences that act as high affinity targets for the vitamin D3 receptor in the absence of the retinoid X receptor. , 1994, Molecular endocrinology.

[66]  H. Samuels,et al.  Interaction of thyroid hormone and retinoic acid receptors on the regulation of the rat growth hormone gene promoter. , 1993, Biochemical and biophysical research communications.

[67]  K. Yamamoto,et al.  Solution structure of the glucocorticoid receptor DNA-binding domain. , 1990, Science.